The global cholesterol screening/ cholesterol lab testing market is experiencing significant growth as cholesterol testing becomes increasingly important across healthcare and laboratory testing environments. The market encompasses cholesterol screening and laboratory testing activities that support the assessment and monitoring of cholesterol levels. Growing attention toward routine screening and laboratory-based testing is contributing to the expansion of the market worldwide. The global market is positioned for continued growth through 2034, reflecting increasing demand for cholesterol testing solutions across healthcare settings.
According to The Insight Partners, the Cholesterol Screening/ Cholesterol Lab Testing Market size is projected to reach US$ 47.53 billion by 2034, increasing from US$ 24.55 billion in 2025. The market is anticipated to register a CAGR of 7.62% during the forecast period 2026-2034. This growth outlook highlights the expanding significance of cholesterol screening and cholesterol laboratory testing within the global healthcare market.
Download Sample PDF:
https://www.theinsightpartners.com/sample/TIPRE00018617
Cholesterol Screening/ Cholesterol Lab Testing Market Size:
The cholesterol screening/ cholesterol lab testing market size is projected to nearly double between 2025 and 2034. The market is expected to increase from US$ 24.55 billion in 2025 to US$ 47.53 billion by 2034, representing an absolute increase of US$ 22.98 billion over the period. The projected market trajectory demonstrates sustained demand for cholesterol screening and laboratory testing. With a 7.62% CAGR from 2026 to 2034, the market is expected to maintain a consistent growth path throughout the forecast period. The increase in market size reflects the expanding role of cholesterol testing within healthcare and laboratory testing activities.
Key Growth Perspective:
The growth of the cholesterol screening/ cholesterol lab testing market is closely associated with the increasing relevance of cholesterol assessment in healthcare. Cholesterol screening and laboratory testing provide important testing capabilities for evaluating cholesterol levels and supporting ongoing monitoring. As healthcare systems continue to utilize laboratory testing, cholesterol testing remains an important component of diagnostic and screening activities. The continued demand for testing is expected to contribute to the expansion of the global market over the coming years.
Cholesterol Lab Testing Market Trends:
Several trends are shaping the development of the cholesterol screening/ cholesterol lab testing market. One important trend is the continued focus on screening and laboratory testing as part of broader healthcare activities. This supports ongoing demand for cholesterol testing across different healthcare environments. Another significant trend is the expanding market opportunity represented by the increasing value of cholesterol testing. The movement from US$ 24.55 billion in 2025 toward US$ 47.53 billion by 2034 indicates a strong long-term growth outlook. The market’s projected 7.62% CAGR also demonstrates that growth is expected to continue steadily rather than being limited to a short-term expansion period. These developments are creating opportunities for companies operating across the cholesterol screening and laboratory testing ecosystem.
Buy Premium Report:https://www.theinsightpartners.com/buy/TIPRE00008520
Top Key Players:
The cholesterol screening/ cholesterol lab testing market includes companies involved in healthcare, laboratory testing, diagnostics, and related testing solutions. Key players associated with the market include:
- Abbott
- Hoffmann-La Roche Ltd
- Danaher Corporation
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Eurofins Scientific
- Sysmex Corporation
- bioMérieux SA
These companies contribute to the competitive landscape through their presence in laboratory testing, diagnostic technologies, healthcare solutions, and related market segments.
Future Outlook for Cholesterol Screening/ Cholesterol Lab Testing Market:
The future outlook for the cholesterol screening/ cholesterol lab testing market remains positive through 2034. The projected increase from US$ 24.55 billion in 2025 to US$ 47.53 billion by 2034 demonstrates substantial market expansion over the forecast period.
The expected 7.62% CAGR during 2026-2034 indicates that cholesterol screening and laboratory testing will continue to represent a growing area within the global healthcare market. As demand for cholesterol testing develops, market participants are expected to benefit from expanding opportunities across screening and laboratory testing activities. From a market-size perspective, the projected growth provides a clear indication of the industry’s long-term potential. The substantial increase in market value over the forecast period reinforces the importance of monitoring market developments, competitive strategies, and emerging opportunities within cholesterol screening and cholesterol laboratory testing.
Trending Reports:
- Dental Prosthetic & Implant Consumables Market Demand, Size & Forecast by 2034
- Prosthetic Liners Market Size, Growth & Demand by 2034
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean|German|Japanese|French|Chinese|Italian|Spanish
